The European community respiratory health survey: What are the main results so far?

European Respiratory Journal

Volumn 18, Issue 3, 2001, Pages 598-611

  Janson, C ^a   Anto, J ^a   Burney, P ^a   Chinn, S ^a   De Marco, R ^a   Heinrich, J ^a   Jarvis, D ^a   Kuenzli, N ^a   Leynaert, B ^a   Luczynska, C ^a   Neukirch, F ^a   Svanes, C ^a   Sunyer, J ^a   Wjst, M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Atopy; Epidemiology; Incidence; Prevalence; Risk factors

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT;

ADULT; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CAT; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; EASTERN EUROPE; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MITE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVIEW; RISK FACTOR; SENSITIZATION; SOUTHERN EUROPE;

ASTHMA; BRONCHIAL HYPERREACTIVITY; DIET; EUROPE; HEALTH SURVEYS; HUMANS; INCIDENCE; OCCUPATIONAL EXPOSURE; PREVALENCE; RESPIRATORY FUNCTION TESTS; RHINITIS; RISK FACTORS;

EID: 17944368023     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.00205801     Document Type: Review

References (104)

1. Changes in asthma prevalence: Two surveys 15 years apart
2. Asthma and allergic rhinitis in Swedish conscripts
3. Prevalence of asthma in Melbourne schoolchildren: Changes over 26 years
4. Increase of asthma and allergic rhinitis prevalence in young Italian men
5. Asthma prevalence in Tokelauan children in two environments
6. Prevalence of asthma: A comparative study of urban and rural Xhosa children
7. Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children
8. Diagnosis and treatment of asthma across Europe
9. The European Community Respiratory Health Survey
10. Developing a new questionnaire for measuring the prevalence and distribution of asthma
11. Validity and repeatability of the IUATLD Bronchial Symptoms Questionnaire: An international comparison
12. References values for forced spirometry
13. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: Implications for multicentre studies
14. Choosing a transformation
15. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
16. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS)
17. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey
18. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey
19. The association of respiratory symptoms and lung function with the use of gas for cooking
20. Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey
21. Genes for asthma? An analysis of the European Community Respiratory Health Survey
22. International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and methods
23. Comparison of asthma prevalence in the ISAAC and the ECRHS
24. International assessment of the internal consistency of respiratory symptoms
25. Prevalence of respiratory symptoms: Marked differences within a small geographical area
26. Higher asthma occurrence in an urban than a suburban area: Role of house dust mite skin allergy
27. Prevalence of asthma and asthma-like symptoms in an adult population sample from Verona
28. Prevalence of asthma and allergic disorders among children in united Germany: A descriptive comparison
29. Atopic sensitization and respiratory symptoms among Polish and Swedish school children
30. Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults: West and east Germany
31. Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden
32. The prevalence of asthmatic respiratory symptoms among adults in Estonian and Swedish university cities
33. Age-dependent differences in the prevalence of allergic rhinitis and atopic sensitization between an eastern and a western German city
34. Is the prevalence of atopic diseases in East and West Germany already converging?
35. Trends in bronchial hyperresponsiveness, respiratory symptoms and lung function among adults: West and East Germany
36. Skin prick tests and specific IgE in adults from three different areas of Sweden
37. Risk factors for asthma in young adults
38. Generational increase of self-reported first attack of asthma in fifteen industrialized countries
39. Paracetamol sales and atopic disease in children and adults: An ecological analysis
40. Prevalence of asthma and asthma-like symptoms in young adults living in three east Anglian towns
41. Prevalence of asthma and asthma-like symptoms in three French cities
42. Symptoms related to asthma and chronic bronchitis in three areas of Sweden
43. The prevalence of asthma and respiratory symptoms among young adults: Is it increasing in Australia?
44. Distribution of total serum IgE and specific IgE to common aeroallergens by sex and age, and their relationship to each other in a random sample of the Dutch general population aged 20-70 years
45. The association of smoking with sensitization to common environmental allergens: Results from the European Community Respiratory Health Survey
46. Prevalence of asthma and asthma-like symptoms in Athens, Greece
47. Risk factors for asthma among young adults in Melbourne, Australia
48. Association between atopic sensitization and asthma and bronchial hyperresponsiveness in swedish adults: Pets, and not mites, are the most important allergens
49. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey
50. Prevalence of bronchial hyperresponsiveness in the southern, central and northern parts of Sweden
51. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study
52. Individual allergens as risk factors for bronchial responsiveness in young adults
53. The association between baseline lung function and bronchial responsiveness to methacholine
54. The association of age, gender and smoking with total IgE and specific IgE
55. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey
56. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking
57. Prevalence of respiratory symptoms, bronchial hyperreactivity, and asthma in a megacity
58. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr)
59. Determinants of bronchial responsiveness in the European Community Respiratory Health Survey in Italy: Evidence of an independent role of atopy, total serum IgE levels, and asthma symptoms
60. Why do only some of the young adults with bronchial hyperreactivity wheeze?
61. Atopy and nonspecific bronchial responsiveness. A population-based assessment
62. Risk of asthma in the general Spanish population attributable to specific immunoresponse
63. Sensitization to individual allergens as risk factors for lower FEV1 in young adults
64. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study
65. Sensitization to individual allergens and bronchial responsiveness in the ECRHS
66. Total serum IgE is associated with asthma independently of specific IgE levels
67. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux
68. Respiratory symptoms, lung function and use of health services among unemployed young adults in Spain
69. Smoking and bronchial responsiveness in nonatopic and atopic young adults
70. Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances
71. Gas cooking and respiratory health in women
72. Absence of association between respiratory symptoms in young adults and use of gas stoves in Belgium
73. Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings
74. Asthma and the indoor environment: The significance of emission of formaldehyde and volatile organic compounds from newly painted indoor surfaces
75. Asthmatic symptoms and indoor levels of micro-organisms and house dust mites
76. Asthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings
77. The risk of asthma attributable to occupational exposures. A population-based study in Spain
78. Occupational asthma in New Zealanders: A population based study
79. Occupational asthma in Europe and other industrialised areas: A population-based study
80. Asthma-related work disability in Sweden. The impact of workplace exposures
81. Fish consumption and respiratory symptoms among young adults in a Norwegian community
82. Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness
83. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona
84. Serology of respiratory viruses in relation to asthma and bronchial hyperresponsiveness
85. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults
86. The association of family size with atopy and atopic disease
87. Childhood environment and adult atopy: Results from the European Community Respiratory Health Survey
88. Serious childhood respiratory infections and asthma in adult life. A population based study
89. Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood
90. Birth characteristics and asthma symptoms in young adults: Results from a population-based cohort study in Norway
91. Undertreatment in a nonselected population of adult patients with asthma
92. Inadequate antiasthma drug use in the north of Italy
93. Individual use of antiasthmatic drugs in the European Community Respiratory Health Survey
94. International variations in asthma treatment compliance: The results of the European Community Respiratory Health Survey (ECRHS)
95. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
96. The prevalence of self-reported asthma and respiratory symptoms in Ankara. Turkey
97. Asthma and allergy in Albania
98. The prevalence of allergic diseases and atopy in Ankara, Turkey: A two-step population-based epidemiological study
99. Skin test reactivity and number of siblings
100. Childhood antecedents of allergic sensitization in young British adults
101. Differences in asthma management around the world